Search research articles
Contact Us
Filters
Showing results (221-230 of 309) with videos related to
Page
of 31
Sort By:
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences
|
September 12, 2022
COVID-19-associated mucormycosis: A review of an emergent epidemic fungal infection in the era of COVID-19 pandemic
Vinay Chamola, Rasoul Mohammadi, Harish Nair, et al.
Frontiers in Microbiology
|
May 27, 2022
Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern
Dàlia Raïch-Regué, Jordana Muñoz-Basagoiti, Daniel Perez-Zsolt, et al.
Infectious Diseases and Therapy
|
April 19, 2023
Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study
Samuel M Brown, Morgan J Katz, Adit A Ginde, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 5, 2009
Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211
Athe M N Tsibris, Roger Paredes, Amy Chadburn, et al.
Journal of Infection and Public Health
|
December 11, 2025
HCV infection, risk factors and PrEP use among HIV-negative MSM and TW at a community health centre
Àngel Rivero, Albert Dalmau-Bueno, Félix Pérez, et al.
Nutrients
|
April 3, 2021
Adherence to a Supplemented Mediterranean Diet Drives Changes in the Gut Microbiota of HIV-1-Infected Individuals
Roque Pastor-Ibáñez, Juan Blanco-Heredia, Florencia Etcheverry, et al.
The Lancet. Infectious Diseases
|
July 17, 2025
Extended nirmatrelvir-ritonavir treatment durations for immunocompromised patients with COVID-19 (EPIC-IC): a placebo-controlled, randomised, double-blind, phase 2 trial
Edward Weinstein, Roger Paredes, Annie Gardner, et al.
Journal for Immunotherapy of Cancer
|
March 30, 2021
Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM)
Maria Gonzalez-Cao, Teresa Puertolas, Mar Riveiro, et al.
Scientific Reports
|
February 2, 2020
Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing
Emma R Lee, Neil Parkin, Cheryl Jennings, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 13, 2025
Doravirine/islatravir (100/0.75 mg) once-daily compared to bictegravir/emtricitabine/tenofovir alafenamide as initial HIV-1 treatment: 48-week results from a phase 3, randomized, controlled, double-blind, non-inferiority trial
Jürgen K Rockstroh, Roger Paredes, Pedro Cahn, et al.
Page
of 31
Search research articles
Search
Showing results (221-230 of 309) with videos related to
Sort By:
Page
of 31
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences
|
September 12, 2022
COVID-19-associated mucormycosis: A review of an emergent epidemic fungal infection in the era of COVID-19 pandemic
Vinay Chamola, Rasoul Mohammadi, Harish Nair, et al.
Frontiers in Microbiology
|
May 27, 2022
Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern
Dàlia Raïch-Regué, Jordana Muñoz-Basagoiti, Daniel Perez-Zsolt, et al.
Infectious Diseases and Therapy
|
April 19, 2023
Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study
Samuel M Brown, Morgan J Katz, Adit A Ginde, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 5, 2009
Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211
Athe M N Tsibris, Roger Paredes, Amy Chadburn, et al.
Journal of Infection and Public Health
|
December 11, 2025
HCV infection, risk factors and PrEP use among HIV-negative MSM and TW at a community health centre
Àngel Rivero, Albert Dalmau-Bueno, Félix Pérez, et al.
Nutrients
|
April 3, 2021
Adherence to a Supplemented Mediterranean Diet Drives Changes in the Gut Microbiota of HIV-1-Infected Individuals
Roque Pastor-Ibáñez, Juan Blanco-Heredia, Florencia Etcheverry, et al.
The Lancet. Infectious Diseases
|
July 17, 2025
Extended nirmatrelvir-ritonavir treatment durations for immunocompromised patients with COVID-19 (EPIC-IC): a placebo-controlled, randomised, double-blind, phase 2 trial
Edward Weinstein, Roger Paredes, Annie Gardner, et al.
Journal for Immunotherapy of Cancer
|
March 30, 2021
Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM)
Maria Gonzalez-Cao, Teresa Puertolas, Mar Riveiro, et al.
Scientific Reports
|
February 2, 2020
Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing
Emma R Lee, Neil Parkin, Cheryl Jennings, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 13, 2025
Doravirine/islatravir (100/0.75 mg) once-daily compared to bictegravir/emtricitabine/tenofovir alafenamide as initial HIV-1 treatment: 48-week results from a phase 3, randomized, controlled, double-blind, non-inferiority trial
Jürgen K Rockstroh, Roger Paredes, Pedro Cahn, et al.
Page
of 31